We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drugmakers Urge Changes to FDA Draft Guidance on Continuous Manufacturing
Drugmakers Urge Changes to FDA Draft Guidance on Continuous Manufacturing
Leading drug manufacturers and trade groups are calling for modifications to the FDA’s draft guidance on continuous manufacturing quality considerations.